SLC25A46
SLC25A46 is a gene that encodes a protein in the human body. This protein is a member of the Solute Carrier Family 25, which is a large family of proteins responsible for the transport of a variety of molecules across the inner membranes of mitochondria. The SLC25A46 protein is involved in the maintenance of mitochondrial morphology and function, and mutations in this gene have been associated with a variety of neurodegenerative diseases.
Function[edit | edit source]
The SLC25A46 protein is localized to the outer mitochondrial membrane and is involved in the maintenance of mitochondrial morphology and function. It is thought to play a role in the fusion of mitochondria, a process that is crucial for maintaining mitochondrial DNA and metabolic function. Mitochondrial fusion is a complex process that involves several different proteins, and disruption of this process can lead to mitochondrial dysfunction and cell death.
Clinical significance[edit | edit source]
Mutations in the SLC25A46 gene have been associated with a variety of neurodegenerative diseases, including Charcot-Marie-Tooth disease, optic atrophy, and Leigh syndrome. These diseases are characterized by progressive degeneration of the nervous system, and are often associated with mitochondrial dysfunction. The exact mechanism by which mutations in the SLC25A46 gene cause these diseases is not fully understood, but it is thought to involve disruption of mitochondrial function.
Research[edit | edit source]
Research into the SLC25A46 gene and its associated diseases is ongoing. Current research is focused on understanding the exact function of the SLC25A46 protein, and how mutations in this gene lead to disease. This research may lead to new treatments for these diseases in the future.
See also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD